External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

JSH 2026

-
Coming soon
11:00 PM
Duration 10mins Utsunomiya, Japan
A phase 1/2 randomized, placebo-controlled study of zilebesiran in Japanese patients with mild-to-moderate hypertension
Kazuomi Kario, Miwa Haranaka, Kenichi Furihata, Yuko Soma, Nathalie Spielewoy, Li Zhao, Alan Shapiro, Daniel Stiglitz, Manoj Khurana, Sandra Nagel, Dion Zappe

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar